New research confirmed the remarkable effectiveness of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir, reported Spotlight (15 October 2024).
SA saw 150,000 new HIV infections in 2023 and aims to reduce this number to 105,000 by 2025 to meet UNAIDS targets, reported Bhekisisa (14 Oct 2024).
Questionable decisions by the trustees of Bonitas Medical Fund and connections with Willem Britz, the former CEO of AfroCentric Distribution Services (ADS), resulted in concerns about the medical scheme’s governance, reported Business Day (14 Oct 2024).
The final report from the Section 59 Investigation Panel, appointed by the CMS to probe allegations of racial profiling and discrimination by medical schemes and their administrators, has been delayed once again until the end of the year - Moneyweb (11 October 2024).